Epidemiology of cardiovascular disease in end-stage renal failure;Pathologie cardiovasculaire de l'insuffisance rénale chronique terminale - Aspects épidémiologiques

Nephrologie

Volumn 23, Issue 7, 2002, Pages 361-365

  Kessler, Michèle ^a  

^a CHU NANCY BRABOIS   (France)

Author keywords

Cardiovascular disease; Chronic kidney disease; Hemodialysis; Peritoneal dialysis

Indexed keywords

CHOLESTEROL; HOMOCYSTEINE; LIPOPROTEIN A;

AGE; ANEMIA; ARTICLE; ATHEROMA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ETHNIC GROUP; GENDER; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS; HUMAN; INFLAMMATION; KIDNEY FAILURE; MORBIDITY; MORTALITY; PERITONEAL DIALYSIS; SMOKING; SYSTOLIC BLOOD PRESSURE; THROMBOGENESIS;

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; RISK FACTORS; SMOKING;

EID: 0036443435     PISSN: 02504960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974; 290: 697-701.
2. Causes of death: USRDS United States Renal Data System. Am J Kidney Dis 1999; 34 (Suppl.): S87-S94.
3. Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999; 10: 1606-15.
4. Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 1999; 56: 2214-9.
5. Jungers P, Khoa TN, Massy ZA, Zingraff J, Labrunie M, Descamps-Latscha B, Man NK. Incidence of atherosclerotic arterial occlusive accidents in predialysis and dialysis patients: A multicentric study in the Ile-de-France district. Nephrol Dial Transplant 1999; 14: 898-902.
6. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32: S112-9.
7. NIH/NIDDK-US Renal Data System Annual Data Report. The National Institute of Diabetes and Digestive and Kidney Disease. Division of Kidney, Urologic and Hematologic Diseases, 1997.
8. National Heart, Lung, Blood Institute. Morbidity and Mortality 1996. Chartbook on Cardiovascular Lung and Blood Diseases. Bethesda MD-US dept of Health and Human Services, 1996.
9. Weinrauch LA, D'elia JA, Healy RW, Gleason RE, Takacs FJ, Libertino JA, Leland OS. Asymptomatic coronary artery disease: Angiography in diabetic patients before renal transplantation. Relation of findings to postoperative survival. Ann Intern Med 1978; 88: 346-8.
10. Manske CL, Wilson RF, Wang Y, Thomas W. Prevalence of, and risk factors for, angiographically determined coronary artery disease in type I-diabetic patients with nephropathy. Arch Intern Med 1992; 152: 2450-5.
11. Beattie JN, Soman SS, Sandberg KR, Yee J, Borzak S, Garg M, McCullough PA. Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis 2001; 37: 1191-200.
12. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995; 47: 186-92.
13. Levin A, Singer J, Thompson CR, Ross H, Lewis M. Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention. Am J Kidney Dis 1996; 27: 347-54.
14. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WR Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-6.
15. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 1996; 11: 1277-85.
16. Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS. Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors. Kidney Int 1995; 47: 884-90.
17. London G. Pathophysiology of cardiovascular damage in the early renal population. Nephrol Dial Transplant 2001; 16: 3-6.
18. London GM, Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME. Arterial wave reflections and survival in end-stage renal failure Hypertension 2001; 38: 434-8.
19. Kannel WB. Hypertension and other risk factors in coronary heart disease. Am Heart J 1987; 114: 918-25.
20. Furth S, Hermann JA, Powe NR Cardiovascular risk factors, comorbidity and survival outcomes in black and white dialysis patients. Semin Dial 1998; 11: 1-4.
21. United States Renal Data System USRDS 1993. Annual Report. The National Institute and Digestive and Kidney Diseases. The National Institute of Health. Bethesda, 1993.
22. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 1996; 49: 1379-85.
23. Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D, Van Stone J, Levey A, Meyer KB, Klag MJ, Johnson HK, Clark E, Sadler JH, Teredesai P. «U» curve association of blood pressure and mortality in hemodialysis patients. Kidney Int 1998; 54: 561-9.
24. Cheung AK, Sarnak MJ, Yah G, Dwyer JT, Heyka RJ, Rocco MV, Teehan BP, Levey AS. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000; 58: 353-62.
25. Charra B, Calemard E, Ruffet M, Chazot C, Terrat JC, Vanel T, Laurent G. Survival as an index of adequacy of dialysis. Kidney Int 1992; 41: 1286-91.
26. Parfrey PS, Griffiths SM, Harnett JD, Taylor R, King A, Hand J, Barre PE. Outcome of congestive heart failure, dilated cardiomyopathy, hypertrophic hyperkinetic disease, and ischemic heart disease in dialysis patients. Am J Nephrol 1990; 10: 213-21.
27. Lowrie EG, Lew NL. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15: 458-82.
28. London GM., Guerin AP, Marchais SJ. Hemodynamic overload in endstage renal disease patients. Semin Dial 1999; 12: 77-83.
29. Bleyer AJ, Russell GB, Satko SG. Sudden and cardiac death rates in hemodialysis patients. Kidney Int 1999; 55: 1553-9.
30. Block GA. Prevalence and clinical consequences of elevated Ca x P product in hemodialysis patients. Clin Nephrol 2000; 54: 318-24.
31. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK. Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001; 12: 2131-8.
32. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease. Am J Kidney Dis 1996; 28: 53-61.
33. Danesh J, Collins R, Peto R. Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies. Circulation 2000; 102: 1082-5.
34. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55: 648-58.
35. Koch M, Kutkuhn B, Grabensee B, Ritz E. Apolipoprotein A, fibrinogen, age, and history of stroke are predictors of death in dialysed diabetic patients: A prospective study in 412 subjects. Nephrol Dial Transplant 1997; 12: 2603-11.
36. Bostom AG, Lathrop L. Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 1997; 52: 10-20.
37. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997; 337: 230-6.
38. Wrone EM, Zehnder JL, Hornberger JM, McCann LM, Coplon NS, Fortmann SP. An MTHFR variant, homocysteine, and cardiovascular comorbidity in renal disease. Kidney Int 2001; 60: 1106-13.
39. Ross R. Atherosclerosis - An inflammatory disease. N Engl J Med 1999; 340: 115-26.
40. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB. Low grade inflammation and coronary heart disease: Prospective study and updated meta-analyses. BMJ 2000; 321: 199-204.
41. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of the literature. Ann Intern Med 1993; 118: 956-63.
42. Culleton BF, Wilson PWF. Thrombogenic risk factors for cardiovascular disease in dialysis patients. Semin Dial 1999; 12: 117-25.